SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '735'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EKJ_A_ACTA3003_0 (BETA-CARBONICANHYDRASE) |
3lvr | ARF-GAP WITH SH3DOMAIN, ANK REPEATAND PHDOMAIN-CONTAININGPROTEIN 3,ADP-RIBOSYLATIONFACTOR 6 (Homosapiens;syntheticconstruct) | 4 / 8 | CYH E 464ASP E 443CYH E 441GLY E 445 | ZN E 735 (-2.2A)None ZN E 735 (-2.4A)None | 0.99A | 1ekjA-3lvrE:undetectable1ekjB-3lvrE:2.6 | 1ekjA-3lvrE:17.141ekjB-3lvrE:17.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_D_BRLD503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | CYH A 276LEU A 344MET A 355HIS A 440LEU A 456TYR A 464 | 735 A 469 (-2.9A)735 A 469 ( 4.2A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 ( 4.8A)735 A 469 (-4.6A) | 1.42A | 1fm6D-2p54A:37.7 | 1fm6D-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_D_BRLD503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | CYH A 276LEU A 344MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 ( 4.2A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.54A | 1fm6D-2p54A:37.7 | 1fm6D-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_D_BRLD503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | CYH A 276SER A 280MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.80A | 1fm6D-2p54A:37.7 | 1fm6D-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FM6_X_BRLX504_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 8 / 12 | ILE A 272PHE A 273CYH A 276SER A 280MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 ( 4.2A)735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.67A | 1fm6X-2p54A:36.9 | 1fm6X-2p54A:61.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1I7Z_A_COCA301_1 (CHIMERA OF IG KAPPACHAIN: HUMANCONSTANT REGION ANDMOUSE VARIABLEREGION) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 4 / 8 | TYR A 464LEU A 287LEU A 460SER A 280 | 735 A 469 (-4.6A)None735 A 469 (-4.3A)735 A 469 (-2.8A) | 1.07A | 1i7zA-2p54A:undetectable | 1i7zA-2p54A:20.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PCG_A_ESTA1_1 (ESTROGEN RECEPTOR) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 10 | LEU A 321ALA A 362ILE A 354HIS A 440LEU A 436 | 735 A 469 ( 4.3A)None735 A 469 (-3.7A)735 A 469 (-4.0A)None | 1.28A | 1pcgA-2p54A:21.3 | 1pcgA-2p54A:24.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZGY_A_BRLA503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | CYH A 276LEU A 344MET A 355HIS A 440LEU A 456TYR A 464 | 735 A 469 (-2.9A)735 A 469 ( 4.2A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 ( 4.8A)735 A 469 (-4.6A) | 1.45A | 1zgyA-2p54A:37.6 | 1zgyA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZGY_A_BRLA503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 8 / 12 | CYH A 276SER A 280LEU A 321LEU A 344MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 ( 4.2A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.69A | 1zgyA-2p54A:37.6 | 1zgyA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ZGY_A_BRLA503_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 8 / 12 | PHE A 273CYH A 276SER A 280LEU A 321LEU A 344MET A 355LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 ( 4.2A)735 A 469 (-2.9A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.93A | 1zgyA-2p54A:37.6 | 1zgyA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_A_BRLA1_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | PHE A 273CYH A 276GLN A 277LEU A 321MET A 355TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-4.4A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.6A) | 0.98A | 2prgA-2p54A:37.3 | 2prgA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_A_BRLA1_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | PHE A 273CYH A 276GLN A 277SER A 280TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-4.4A)735 A 469 (-2.8A)735 A 469 (-4.6A) | 0.99A | 2prgA-2p54A:37.3 | 2prgA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_A_BRLA1_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | PHE A 273CYH A 276LEU A 321MET A 355HIS A 440TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.6A) | 0.83A | 2prgA-2p54A:37.3 | 2prgA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_A_BRLA1_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | PHE A 273CYH A 276SER A 280HIS A 440TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 (-4.0A)735 A 469 (-4.6A) | 0.97A | 2prgA-2p54A:37.3 | 2prgA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_B_BRLB2_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | CYH A 276SER A 280LEU A 321MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.81A | 2prgB-2p54A:35.1 | 2prgB-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PRG_B_BRLB2_1 (PEROXISOMEPROLIFERATORACTIVATED RECEPTORGAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | PHE A 273CYH A 276SER A 280LEU A 321MET A 355LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.91A | 2prgB-2p54A:35.1 | 2prgB-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | CYH A 276ILE A 339HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 ( 4.1A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 1.42A | 2xkwA-2p54A:37.1 | 2xkwA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | CYH A 276MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.91A | 2xkwA-2p54A:37.1 | 2xkwA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | LEU A 321ILE A 339HIS A 440LEU A 460TYR A 464 | 735 A 469 ( 4.3A)735 A 469 ( 4.1A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 1.04A | 2xkwA-2p54A:37.1 | 2xkwA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | PHE A 273CYH A 276ILE A 339LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 ( 4.1A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 1.31A | 2xkwA-2p54A:37.1 | 2xkwA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | PHE A 273CYH A 276MET A 355LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.9A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.97A | 2xkwA-2p54A:37.1 | 2xkwA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | PHE A 273LEU A 321ILE A 339LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 ( 4.3A)735 A 469 ( 4.1A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 1.47A | 2xkwA-2p54A:37.1 | 2xkwA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | PHE A 273SER A 280LEU A 321MET A 355LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.70A | 2xkwA-2p54A:37.1 | 2xkwA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | SER A 280LEU A 321MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.63A | 2xkwA-2p54A:37.1 | 2xkwA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_A_P1BA1478_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 4 / 7 | LEU A 247ILE A 272GLN A 277ILE A 317 | None735 A 469 ( 4.2A)735 A 469 (-4.4A)735 A 469 ( 4.8A) | 0.49A | 2xkwA-2p54A:37.1 | 2xkwA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_B_P1BB1475_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | ILE A 241GLU A 251SER A 280LEU A 321MET A 355 | 735 A 469 (-4.7A)None735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A) | 0.59A | 2xkwB-2p54A:34.0 | 2xkwB-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2XKW_B_P1BB1475_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 6 | LEU A 247ARG A 271ILE A 272ILE A 317MET A 320 | NoneNone735 A 469 ( 4.2A)735 A 469 ( 4.8A)None | 0.84A | 2xkwB-2p54A:34.0 | 2xkwB-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 10 | GLU A 251ARG A 271ILE A 272LEU A 321MET A 355 | NoneNone735 A 469 ( 4.2A)735 A 469 ( 4.3A)735 A 469 (-2.9A) | 0.93A | 3adsA-2p54A:37.1 | 3adsA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 8 / 12 | PHE A 273CYH A 276LEU A 321LEU A 344LYS A 358HIS A 440LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 ( 4.3A)735 A 469 ( 4.2A)None735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.87A | 3adsA-2p54A:37.1 | 3adsA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 8 / 12 | PHE A 273SER A 280LEU A 321LEU A 344LYS A 358HIS A 440LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 ( 4.2A)None735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.64A | 3adsA-2p54A:37.1 | 3adsA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_A_IMNA2_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 6 | ILE A 272ILE A 317LEU A 347PHE A 351MET A 355 | 735 A 469 ( 4.2A)735 A 469 ( 4.8A)NoneNone735 A 469 (-2.9A) | 0.38A | 3adsA-2p54A:37.1 | 3adsA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADS_B_IMNB3_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | ILE A 272SER A 280ILE A 317LEU A 321MET A 355 | 735 A 469 ( 4.2A)735 A 469 (-2.8A)735 A 469 ( 4.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A) | 0.51A | 3adsB-2p54A:33.9 | 3adsB-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 8 / 12 | PHE A 273CYH A 276GLN A 277LEU A 321LEU A 344HIS A 440LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-4.4A)735 A 469 ( 4.3A)735 A 469 ( 4.2A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.89A | 3adxA-2p54A:37.2 | 3adxA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 8 / 12 | PHE A 273GLN A 277SER A 280LEU A 321LEU A 344HIS A 440LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-4.4A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 ( 4.2A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.66A | 3adxA-2p54A:37.2 | 3adxA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ADX_A_IMNA2_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 7 | ILE A 272ILE A 317LEU A 347PHE A 351MET A 355LYS A 358 | 735 A 469 ( 4.2A)735 A 469 ( 4.8A)NoneNone735 A 469 (-2.9A)None | 0.40A | 3adxA-2p54A:37.2 | 3adxA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | CYH A 276SER A 280LEU A 321MET A 355HIS A 440 | 735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.0A) | 0.99A | 3cs8A-2p54A:37.5 | 3cs8A-2p54A:61.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | SER A 280ILE A 317LEU A 321MET A 355LEU A 460TYR A 464 | 735 A 469 (-2.8A)735 A 469 ( 4.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.67A | 3cs8A-2p54A:37.5 | 3cs8A-2p54A:61.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | SER A 280LEU A 321MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.91A | 3cs8A-2p54A:37.5 | 3cs8A-2p54A:61.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3CS8_A_BRLA503_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | SER A 280LEU A 321MET A 355LYS A 358HIS A 440TYR A 464 | 735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)None735 A 469 (-4.0A)735 A 469 (-4.6A) | 0.98A | 3cs8A-2p54A:37.5 | 3cs8A-2p54A:61.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_D_BRLD478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 8 / 12 | PHE A 273CYH A 276SER A 280LEU A 321LEU A 344MET A 355HIS A 440TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 ( 4.2A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.6A) | 0.92A | 3dzyD-2p54A:34.7 | 3dzyD-2p54A:51.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3DZY_D_BRLD478_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | PHE A 273CYH A 276SER A 280LEU A 347HIS A 440TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)None735 A 469 (-4.0A)735 A 469 (-4.6A) | 1.42A | 3dzyD-2p54A:34.7 | 3dzyD-2p54A:51.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 10 / 12 | CYH A 275CYH A 276SER A 280TYR A 314MET A 330ILE A 339ILE A 354HIS A 440VAL A 444TYR A 464 | 735 A 469 ( 4.0A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 (-3.9A)735 A 469 ( 3.2A)735 A 469 ( 4.1A)735 A 469 (-3.7A)735 A 469 (-4.0A)735 A 469 ( 3.9A)735 A 469 (-4.6A) | 0.67A | 3g8iA-2p54A:40.0 | 3g8iA-2p54A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 10 / 12 | CYH A 275CYH A 276TYR A 314MET A 330ILE A 339ILE A 354MET A 355HIS A 440VAL A 444TYR A 464 | 735 A 469 ( 4.0A)735 A 469 (-2.9A)735 A 469 (-3.9A)735 A 469 ( 3.2A)735 A 469 ( 4.1A)735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 ( 3.9A)735 A 469 (-4.6A) | 0.87A | 3g8iA-2p54A:40.0 | 3g8iA-2p54A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | SER A 280TYR A 314MET A 325ILE A 354HIS A 440VAL A 444TYR A 464 | 735 A 469 (-2.8A)735 A 469 (-3.9A)None735 A 469 (-3.7A)735 A 469 (-4.0A)735 A 469 ( 3.9A)735 A 469 (-4.6A) | 1.24A | 3g8iA-2p54A:40.0 | 3g8iA-2p54A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | TYR A 314MET A 325ILE A 354MET A 355HIS A 440VAL A 444TYR A 464 | 735 A 469 (-3.9A)None735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 ( 3.9A)735 A 469 (-4.6A) | 1.11A | 3g8iA-2p54A:40.0 | 3g8iA-2p54A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | VAL A 255CYH A 275CYH A 276ILE A 354TYR A 314 | 735 A 469 (-4.0A)735 A 469 ( 4.0A)735 A 469 (-2.9A)735 A 469 (-3.7A)735 A 469 (-3.9A) | 1.33A | 3g8iA-2p54A:40.0 | 3g8iA-2p54A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 10 / 12 | VAL A 255CYH A 275CYH A 276SER A 280TYR A 314MET A 330ILE A 339ILE A 354VAL A 444TYR A 464 | 735 A 469 (-4.0A)735 A 469 ( 4.0A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 (-3.9A)735 A 469 ( 3.2A)735 A 469 ( 4.1A)735 A 469 (-3.7A)735 A 469 ( 3.9A)735 A 469 (-4.6A) | 0.78A | 3g8iA-2p54A:40.0 | 3g8iA-2p54A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G8I_A_RO7A1_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 7 | LEU A 247GLN A 277LEU A 321VAL A 332LEU A 344LYS A 358LEU A 460 | None735 A 469 (-4.4A)735 A 469 ( 4.3A)735 A 469 (-3.8A)735 A 469 ( 4.2A)None735 A 469 (-4.3A) | 0.64A | 3g8iA-2p54A:40.0 | 3g8iA-2p54A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | CYH A 276LEU A 321ILE A 339LYS A 358HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 ( 4.3A)735 A 469 ( 4.1A)None735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 1.39A | 3g9eA-2p54A:37.6 | 3g9eA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3G9E_A_RO7A1_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | CYH A 276SER A 280LYS A 358HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-2.8A)None735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.86A | 3g9eA-2p54A:37.6 | 3g9eA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_A_EPAA1_1 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 10 | PHE A 273GLN A 277ILE A 317MET A 320VAL A 332LEU A 344LYS A 358 | 735 A 469 (-3.7A)735 A 469 (-4.4A)735 A 469 ( 4.8A)None735 A 469 (-3.8A)735 A 469 ( 4.2A)None | 0.49A | 3gwxA-2p54A:37.9 | 3gwxA-2p54A:70.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_A_EPAA1_2 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | CYH A 276THR A 279THR A 283HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-3.6A)None735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.47A | 3gwxA-2p54A:37.9 | 3gwxA-2p54A:70.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_A_EPAA1_2 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | CYH A 276THR A 283ILE A 354HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)None735 A 469 (-3.7A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.77A | 3gwxA-2p54A:37.9 | 3gwxA-2p54A:70.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_B_EPAB3_1 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 9 / 12 | CYH A 276THR A 279THR A 283GLU A 286LEU A 321LYS A 358HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-3.6A)NoneNone735 A 469 ( 4.3A)None735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.64A | 3gwxB-2p54A:38.0 | 3gwxB-2p54A:70.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_B_EPAB3_1 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | THR A 279ILE A 339LYS A 358HIS A 440LEU A 460TYR A 464 | 735 A 469 (-3.6A)735 A 469 ( 4.1A)None735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 1.49A | 3gwxB-2p54A:38.0 | 3gwxB-2p54A:70.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GWX_B_EPAB3_2 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | LEU A 247PHE A 273GLN A 277ILE A 317MET A 320VAL A 332LEU A 344 | None735 A 469 (-3.7A)735 A 469 (-4.4A)735 A 469 ( 4.8A)None735 A 469 (-3.8A)735 A 469 ( 4.2A) | 0.59A | 3gwxB-2p54A:38.0 | 3gwxB-2p54A:70.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QT0_A_486A4_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | CYH A 276LEU A 321ILE A 339LYS A 358HIS A 440 | 735 A 469 (-2.9A)735 A 469 ( 4.3A)735 A 469 ( 4.1A)None735 A 469 (-4.0A) | 1.45A | 3qt0A-2p54A:36.6 | 3qt0A-2p54A:61.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQW_C_ACHC323_0 (ELIC PENTAMERICLIGAND GATED IONCHANNEL FROM ERWINIACHRYSANTHEMI) |
1w6j | LANOSTEROL SYNTHASE (Homosapiens) | 4 / 8 | PHE A 195GLU A 519TYR A 237LEU A 211 | NoneNoneC14 A1735 ( 4.4A)None | 1.15A | 3rqwC-1w6jA:2.23rqwD-1w6jA:2.4 | 3rqwC-1w6jA:16.553rqwD-1w6jA:16.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQW_J_ACHJ323_0 (ELIC PENTAMERICLIGAND GATED IONCHANNEL FROM ERWINIACHRYSANTHEMI) |
1w6j | LANOSTEROL SYNTHASE (Homosapiens) | 4 / 8 | GLU A 519TYR A 237LEU A 211PHE A 195 | NoneC14 A1735 ( 4.4A)NoneNone | 1.10A | 3rqwF-1w6jA:1.73rqwJ-1w6jA:undetectable | 3rqwF-1w6jA:16.553rqwJ-1w6jA:16.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP6_A_IL2A901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 12 / 12 | PHE A 273CYH A 275CYH A 276THR A 279SER A 280TYR A 314VAL A 332ILE A 354MET A 355HIS A 440VAL A 444TYR A 464 | 735 A 469 (-3.7A)735 A 469 ( 4.0A)735 A 469 (-2.9A)735 A 469 (-3.6A)735 A 469 (-2.8A)735 A 469 (-3.9A)735 A 469 (-3.8A)735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 ( 3.9A)735 A 469 (-4.6A) | 0.32A | 3sp6A-2p54A:41.7 | 3sp6A-2p54A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP6_A_IL2A901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | PHE A 273CYH A 275CYH A 276TYR A 464ILE A 354HIS A 440 | 735 A 469 (-3.7A)735 A 469 ( 4.0A)735 A 469 (-2.9A)735 A 469 (-4.6A)735 A 469 (-3.7A)735 A 469 (-4.0A) | 1.47A | 3sp6A-2p54A:41.7 | 3sp6A-2p54A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP6_A_IL2A901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | TYR A 314VAL A 324MET A 355HIS A 440TYR A 464 | 735 A 469 (-3.9A)None735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.6A) | 1.50A | 3sp6A-2p54A:41.7 | 3sp6A-2p54A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP9_A_IL2A901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | LEU A 247CYH A 276THR A 279ILE A 317ILE A 354 | None735 A 469 (-2.9A)735 A 469 (-3.6A)735 A 469 ( 4.8A)735 A 469 (-3.7A) | 1.07A | 3sp9A-2p54A:37.5 | 3sp9A-2p54A:70.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP9_A_IL2A901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | LEU A 247PHE A 273CYH A 276THR A 279ILE A 317HIS A 440TYR A 464 | None735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-3.6A)735 A 469 ( 4.8A)735 A 469 (-4.0A)735 A 469 (-4.6A) | 1.32A | 3sp9A-2p54A:37.5 | 3sp9A-2p54A:70.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP9_A_IL2A901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | LEU A 258PHE A 273CYH A 276THR A 279ILE A 317HIS A 440TYR A 464 | None735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-3.6A)735 A 469 ( 4.8A)735 A 469 (-4.0A)735 A 469 (-4.6A) | 1.27A | 3sp9A-2p54A:37.5 | 3sp9A-2p54A:70.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP9_B_IL2B901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | LEU A 247PHE A 273CYH A 276THR A 279ILE A 317HIS A 440TYR A 464 | None735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-3.6A)735 A 469 ( 4.8A)735 A 469 (-4.0A)735 A 469 (-4.6A) | 1.31A | 3sp9B-2p54A:37.7 | 3sp9B-2p54A:70.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3SP9_B_IL2B901_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR DELTA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | LEU A 258PHE A 273CYH A 276THR A 279ILE A 317HIS A 440TYR A 464 | None735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-3.6A)735 A 469 ( 4.8A)735 A 469 (-4.0A)735 A 469 (-4.6A) | 1.29A | 3sp9B-2p54A:37.7 | 3sp9B-2p54A:70.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_D_RTZD2_1 (CYTOCHROME P450 2D6) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 9 | LEU A 247THR A 246LEU A 344THR A 340ILE A 339 | NoneNone735 A 469 ( 4.2A)None735 A 469 ( 4.1A) | 1.01A | 3tbgD-2p54A:undetectable | 3tbgD-2p54A:18.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UCJ_A_AZMA229_1 (CARBONIC ANHYDRASE) |
3lvr | ARF-GAP WITH SH3DOMAIN, ANK REPEATAND PHDOMAIN-CONTAININGPROTEIN 3,ADP-RIBOSYLATIONFACTOR 6 (Homosapiens;syntheticconstruct) | 5 / 10 | CYH E 464ASP E 443CYH E 441GLY E 445ALA E 446 | ZN E 735 (-2.2A)None ZN E 735 (-2.4A)None ZN E 735 ( 4.4A) | 1.17A | 3ucjA-3lvrE:4.3 | 3ucjA-3lvrE:18.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UCJ_B_AZMB229_2 (CARBONIC ANHYDRASE) |
3lvr | ARF-GAP WITH SH3DOMAIN, ANK REPEATAND PHDOMAIN-CONTAININGPROTEIN 3,ADP-RIBOSYLATIONFACTOR 6 (Homosapiens;syntheticconstruct) | 5 / 10 | CYH E 464ASP E 443CYH E 441GLY E 445ALA E 446 | ZN E 735 (-2.2A)None ZN E 735 (-2.4A)None ZN E 735 ( 4.4A) | 1.13A | 3ucjB-3lvrE:undetectable | 3ucjB-3lvrE:18.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3VN2_A_TLSA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 9 / 12 | PHE A 273CYH A 276SER A 280ILE A 317LEU A 321LEU A 344MET A 355HIS A 440TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.8A)735 A 469 ( 4.3A)735 A 469 ( 4.2A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.6A) | 0.51A | 3vn2A-2p54A:38.6 | 3vn2A-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4EMA_A_BRLA601_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | CYH A 276SER A 280LEU A 321MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.75A | 4emaA-2p54A:36.7 | 4emaA-2p54A:61.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O1E_A_C2FA3000_0 (DIHYDROPTEROATESYNTHASE DHPS) |
4flx | DNA POLYMERASE 1 (Pyrococcusabyssi) | 5 / 12 | ILE A 666LEU A 670GLY A 677SER A 711ASN A 735 | ILE A 666 ( 0.7A)LEU A 670 ( 0.5A)GLY A 677 ( 0.0A)SER A 711 ( 0.0A)ASN A 735 ( 0.6A) | 1.20A | 4o1eA-4flxA:undetectable | 4o1eA-4flxA:18.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O1E_A_C2FA3000_0 (DIHYDROPTEROATESYNTHASE DHPS) |
4flx | DNA POLYMERASE 1 (Pyrococcusabyssi) | 5 / 12 | ILE A 702ILE A 666LEU A 670GLY A 677ASN A 735 | ILE A 702 ( 0.7A)ILE A 666 ( 0.7A)LEU A 670 ( 0.5A)GLY A 677 ( 0.0A)ASN A 735 ( 0.6A) | 1.09A | 4o1eA-4flxA:undetectable | 4o1eA-4flxA:18.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_A_BRLA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | CYH A 276SER A 280MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.71A | 4o8fA-2p54A:34.9 | 4o8fA-2p54A:61.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_A_BRLA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | PHE A 273CYH A 276SER A 280MET A 355LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 (-2.9A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.73A | 4o8fA-2p54A:34.9 | 4o8fA-2p54A:61.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_A_BRLA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | SER A 280VAL A 324HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.8A)None735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 1.24A | 4o8fA-2p54A:34.9 | 4o8fA-2p54A:61.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_B_BRLB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | CYH A 276LEU A 321MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.76A | 4o8fB-2p54A:34.5 | 4o8fB-2p54A:61.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_B_BRLB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | CYH A 276MET A 355HIS A 440LEU A 456TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 ( 4.8A)735 A 469 (-4.6A) | 1.49A | 4o8fB-2p54A:34.5 | 4o8fB-2p54A:61.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_B_BRLB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | CYH A 276SER A 280LEU A 321HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.90A | 4o8fB-2p54A:34.5 | 4o8fB-2p54A:61.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_B_BRLB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | HIS A 440LEU A 321VAL A 324LEU A 460TYR A 464 | 735 A 469 (-4.0A)735 A 469 ( 4.3A)None735 A 469 (-4.3A)735 A 469 (-4.6A) | 1.45A | 4o8fB-2p54A:34.5 | 4o8fB-2p54A:61.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4O8F_B_BRLB501_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 4 / 6 | ILE A 272PHE A 273ILE A 317LEU A 344 | 735 A 469 ( 4.2A)735 A 469 (-3.7A)735 A 469 ( 4.8A)735 A 469 ( 4.2A) | 0.74A | 4o8fB-2p54A:34.5 | 4o8fB-2p54A:61.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XLD_A_BRLA502_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 8 / 12 | PHE A 273CYH A 276SER A 280LEU A 321MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.81A | 4xldA-2p54A:36.7 | 4xldA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XTA_A_DIFA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 4 / 9 | SER A 280GLU A 286MET A 320LEU A 321 | 735 A 469 (-2.8A)NoneNone735 A 469 ( 4.3A) | 0.39A | 4xtaA-2p54A:35.1 | 4xtaA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XTA_B_DIFB501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 4 / 8 | ILE A 272SER A 280LEU A 321MET A 355 | 735 A 469 ( 4.2A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A) | 0.61A | 4xtaB-2p54A:33.4 | 4xtaB-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4XUM_A_IMNA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 9 / 12 | PHE A 273CYH A 276SER A 280ILE A 317MET A 355HIS A 440LEU A 456LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.8A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 ( 4.8A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.69A | 4xumA-2p54A:37.3 | 4xumA-2p54A:61.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5B8I_C_FK5C201_1 (SERINE/THREONINE-PROTEIN PHOSPHATASEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE) |
4jjj | CELLULOSE1,4-BETA-CELLOBIOSIDASE (Thermobifidafusca) | 4 / 6 | LEU A 604SER A 548PRO A 547GLU A 40 | None ZN A 735 (-3.9A)NoneCBK A 702 ( 3.4A) | 1.17A | 5b8iA-4jjjA:undetectable | 5b8iA-4jjjA:19.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JI0_D_BRLD501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | CYH A 276SER A 280LEU A 321MET A 355HIS A 440TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.6A) | 0.84A | 5ji0D-2p54A:37.5 | 5ji0D-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JI0_D_BRLD501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | PHE A 273CYH A 276GLN A 277SER A 280LEU A 321MET A 355 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-4.4A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A) | 1.05A | 5ji0D-2p54A:37.5 | 5ji0D-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5JI0_D_BRLD501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | PHE A 273CYH A 276SER A 280LEU A 321MET A 355TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.6A) | 1.19A | 5ji0D-2p54A:37.5 | 5ji0D-2p54A:61.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2O_A_8N6A501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | CYH A 276SER A 280LEU A 321MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.72A | 5y2oA-2p54A:37.5 | 5y2oA-2p54A:12.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2O_A_8N6A501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | PHE A 273CYH A 276SER A 280LEU A 321MET A 355LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.82A | 5y2oA-2p54A:37.5 | 5y2oA-2p54A:12.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_A_8LXA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | LEU A 247CYH A 276LEU A 321MET A 355HIS A 440 | None735 A 469 (-2.9A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.0A) | 0.84A | 5y2tA-2p54A:36.2 | 5y2tA-2p54A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_A_8LXA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | LEU A 247PHE A 273CYH A 276GLN A 277LEU A 321MET A 355 | None735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-4.4A)735 A 469 ( 4.3A)735 A 469 (-2.9A) | 0.72A | 5y2tA-2p54A:36.2 | 5y2tA-2p54A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_A_8LXA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | PHE A 273CYH A 276GLN A 277LEU A 321ILE A 339 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-4.4A)735 A 469 ( 4.3A)735 A 469 ( 4.1A) | 1.23A | 5y2tA-2p54A:36.2 | 5y2tA-2p54A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_B_8LXB501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | LEU A 247ARG A 271ILE A 272CYH A 276GLN A 277ILE A 317HIS A 440 | NoneNone735 A 469 ( 4.2A)735 A 469 (-2.9A)735 A 469 (-4.4A)735 A 469 ( 4.8A)735 A 469 (-4.0A) | 0.98A | 5y2tB-2p54A:34.2 | 5y2tB-2p54A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_B_8LXB501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | LEU A 247ILE A 272CYH A 276GLN A 277ILE A 317LEU A 321HIS A 440 | None735 A 469 ( 4.2A)735 A 469 (-2.9A)735 A 469 (-4.4A)735 A 469 ( 4.8A)735 A 469 ( 4.3A)735 A 469 (-4.0A) | 0.75A | 5y2tB-2p54A:34.2 | 5y2tB-2p54A:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YCN_A_8LXA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | LEU A 247ILE A 272LEU A 321MET A 355LEU A 460 | None735 A 469 ( 4.2A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.3A) | 0.62A | 5ycnA-2p54A:37.6 | 5ycnA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YCN_A_8LXA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 4 / 6 | CYH A 276SER A 280HIS A 440TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 (-4.0A)735 A 469 (-4.6A) | 0.68A | 5ycnA-2p54A:37.6 | 5ycnA-2p54A:61.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5YCN_A_8LXA501_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 4 / 6 | PHE A 273CYH A 276SER A 280TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 (-4.6A) | 0.52A | 5ycnA-2p54A:37.6 | 5ycnA-2p54A:61.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YCP_A_BRLA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 6 / 12 | CYH A 276LEU A 321ILE A 339HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 ( 4.3A)735 A 469 ( 4.1A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 1.37A | 5ycpA-2p54A:38.0 | 5ycpA-2p54A:17.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YCP_A_BRLA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | CYH A 276SER A 280LEU A 321MET A 355HIS A 440LEU A 460TYR A 464 | 735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.76A | 5ycpA-2p54A:38.0 | 5ycpA-2p54A:17.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YCP_A_BRLA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | PHE A 273CYH A 276SER A 280LEU A 321MET A 355LEU A 460TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.3A)735 A 469 (-4.6A) | 0.90A | 5ycpA-2p54A:38.0 | 5ycpA-2p54A:17.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MD4_A_BRLA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 5 / 12 | PHE A 273CYH A 276GLN A 277HIS A 440TYR A 314 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-4.4A)735 A 469 (-4.0A)735 A 469 (-3.9A) | 1.48A | 6md4A-2p54A:36.5 | 6md4A-2p54A:16.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MD4_A_BRLA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 7 / 12 | PHE A 273CYH A 276GLN A 277LEU A 321ILE A 339HIS A 440TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-4.4A)735 A 469 ( 4.3A)735 A 469 ( 4.1A)735 A 469 (-4.0A)735 A 469 (-4.6A) | 1.39A | 6md4A-2p54A:36.5 | 6md4A-2p54A:16.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MD4_A_BRLA501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
2p54 | PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR ALPHA (Homosapiens) | 8 / 12 | PHE A 273CYH A 276GLN A 277SER A 280LEU A 321MET A 355HIS A 440TYR A 464 | 735 A 469 (-3.7A)735 A 469 (-2.9A)735 A 469 (-4.4A)735 A 469 (-2.8A)735 A 469 ( 4.3A)735 A 469 (-2.9A)735 A 469 (-4.0A)735 A 469 (-4.6A) | 0.70A | 6md4A-2p54A:36.5 | 6md4A-2p54A:16.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MHT_D_SAMD328_0 (CYTOSINE-SPECIFICMETHYLTRANSFERASEHHAI) |
4c1o | BETA-XYLOSIDASE (Parageobacillusthermoglucosidasius) | 5 / 12 | PHE A 185GLY A 52GLY A 49ASP A 55ILE A 215 | NoneNoneEDO A1735 (-2.9A)NoneNone | 1.10A | 6mhtA-4c1oA:undetectable | 6mhtA-4c1oA:18.47 |